Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Non-Small Cell Lung Cancer

China’s Regulator Accepts Amgen’s Sotorasib for Breakthrough Therapy Designation as a First Milestone

Amgen, a leading global biotech company based in Southern California reported a first—the first time it has successfully achieved Breakthrough […]

China’s Regulator Accepts Amgen’s Sotorasib for Breakthrough Therapy Designation as a First Milestone
1 month ago
Share

Asan Medical Center Reports on Promising Results of Lazertinib in Patients with Non-Small Cell Lung Cancer

Yuhan Corp reports that it made three poster presentations at the virtual meeting of the American Society of Clinical Oncology […]

Asan Medical Center Reports on Promising Results of Lazertinib in Patients with Non-Small Cell Lung Cancer
9 months ago
Share

Sanofi & Regeneron Phase III Lung Cancer Drug Trial Stopped Early Due to Significant Improvement in Overall Survival

Although Sanofi and Regeneron are not in the current PD-1/PD-L1 market mix they are scrambling to be with Libtayo (cemiplimab) […]

Sanofi & Regeneron Phase III Lung Cancer Drug Trial Stopped Early Due to Significant Improvement in Overall Survival
10 months ago
Share

Flinders University Investigators Find High BMI Actually Helps Cancer Immunotherapy Patients

Medical research has established that a high Body Mass Index (BMI) adversely impacts one’s risk for obesity, diabetes, cardiovascular, and […]

Flinders University Investigators Find High BMI Actually Helps Cancer Immunotherapy Patients
1 year ago
Share

Dr. Lyudmila Bazhenova, MD & Immuno-Oncology Clinical Investigator Discusses Adverse Events

Dr. Lyudmila Bazhenova, professor of Medicine and thoracic oncologist with the University of California San Diego, and active principal investigator in […]

Dr. Lyudmila Bazhenova, MD & Immuno-Oncology Clinical Investigator Discusses Adverse Events
1 year ago
Share

Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy

 Vaccitech Ltd announced today, December 18th, 2019, that its strategic collaboration with the Ludwig Institute for Cancer Research (Ludwig), Vaccitech Oncology […]

Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase IIIa Clinical Trial as First-Line NSCLC Therapy
1 year ago
Share

Clinical Trials Lead to New Standard of Care for Lung Cancer Patients

Clinical trials results have contributed to a new standard of care for lung cancer patients. The results from several of the […]

Clinical Trials Lead to New Standard of Care for Lung Cancer Patients
1 year ago
Share

Investigational Drug Shows Promise in Patients with RET-Altered Cancers

Patients with RET-fusion-positive non-small cell lung cancer (NSCLC) had a high response to LOXO-292 (selpercatinib), according to findings from the […]

Cantargia Reports Interim Data from Phase 2A CANFOUR Trial of CAN04 in Pancreatic and Lung Cancers
1 year ago
Share

Leading KRAS Inhibitor Candidate for Patients with Lung & Colon Cancer, MRTX849 Producing Positive Data in Phase I Trial

In a Phase 1/2 trial MRTX849, an investigational KRAS G12C inhibitor has demonstrated clinical activity, including objective responses in patients […]

Leading KRAS Inhibitor Candidate for Patients with Lung & Colon Cancer, MRTX849 Producing Positive Data in Phase I Trial
1 year ago
Share

OncLive Peer Exchange Provides Perspective on How the Latest Research from the World Conference for Lung Cancer and the ESMO Annual Meetings Translate to Patient Care and Clinical Practice

Suresh S. Ramalingam, MD, FASCO, Winship Canter Institute of Emery University, leads the discussion on the impact of overall survival […]

OncLive Peer Exchange Provides Perspective on How the Latest Research from the World Conference for Lung Cancer and the ESMO Annual Meetings Translate to Patient Care and Clinical Practice
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.